The deal priced below last closing price of $2.38. RBC Capital is acting as lead book running manager for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LIFE:
- aTyr Pharma Announces Commencement of Public Offering of Common Stock
- aTyr Pharma announces common stock offering, no amount given
- aTyr Pharma announces achievement of milestone by partner Kyorin Pharmaceutical
- aTyr Pharma to present new data on mechanism of action of efzofitimod
- aTyr: EPO okays use of efzofitimod with pirfenidone patent for lung inflammation